4//SEC Filing
Doebele Robert 4
Accession 0001104659-23-023387
CIK 0001724979other
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 6:18 PM ET
Size
5.7 KB
Accession
0001104659-23-023387
Insider Transaction Report
Form 4
Doebele Robert
EVP, Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-02-15+123,325→ 123,325 totalExercise: $9.30Exp: 2033-02-15→ Common Stock (123,325 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase a total of 123,325 shares of the Issuer's common stock, one quarter of which will vest on February 15, 2024, with the remaining three quarters vesting in equal monthly installments through February 15, 2027, subject to the Reporting Person's continued service to the Issuer.
Documents
Issuer
Rain Oncology Inc.
CIK 0001724979
Entity typeother
Related Parties
1- filerCIK 0001856681
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 6:18 PM ET
- Size
- 5.7 KB